Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Largest group on African continent introduced to Sign Language
2016-07-05

Description: z UFS101 SASL Tags: z UFS101 SASL

The introduction of basic Sign Language
as part of the UFS101 course was a great
success. From left are Susan Lombaard,
Annemarie le Roux, Tshisikhawe Dzivhani
(all from the Department of South African
Sign Language), and Lauren Oosthuizen
(UFS101).

Photo: Leonie Bolleurs

As a result of a new initiative at the University of the Free State (UFS), the largest group of students on the African continent took part in a first-year seminar which included Sign Language.

A total of 5400 students on the Bloemfontein Campus and 1000 on Qwaqwa Campus were taught basic Sign Language by Susan Lombaard, Acting Head of the Department of South African Sign Language, and her team members, Tshisikhawe Dzivhani, Annemarie le Roux, and Nicolene de Klerk.

It forms part of the UFS101 module presented to all first-year students. The initiative, begun in the first semester of 2016, will form part of UFS101 in future and was met with an overwhelmingly positive response.

Three segments of course

Sign Language was taught in three segments and positioned as large-class learning experiences in the Callie Human Centre (Bloemfontein Campus) and the Nelson Mandela Hall (Qwaqwa Campus). Students were taught about deaf culture, Sign Language theory, as well as how to sign their names, exchange pleasantries, and have a basic conversation.

A valuable skill to have

“It (the Sign Language experience) was very interesting and helpful,” said one of the students. “It is important to have the ability to communicate with all sorts of people, and to be able to help them in a crisis”. According to another, it sparked an interest in Sign Language. “It is a skill I will continue to use and try to learn more from it,” said a third.

Lombaard – in collaboration with the UFS101 team – will be presenting a paper related to this achievement at the DeafNet Africa Conference in Johannesburg, from 26 to 30 September 2016.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept